• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARTHREX, INC. SUTR ANCH,BIO-COMP P-LCK,2.9X 12.5MM; BIO SOFT TISSUE FIXATN FASTNR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARTHREX, INC. SUTR ANCH,BIO-COMP P-LCK,2.9X 12.5MM; BIO SOFT TISSUE FIXATN FASTNR Back to Search Results
Model Number SUTR ANCH,BIO-COMP P-LCK,2.9X 12.5MM
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/21/2024
Type of Reportable Event Malfunction
Event or Problem Description
On 3/22/2024, it was reported by a sales representative via email that an ar-2923bc biocomposite pushlock anchor split in half during insertion.The broken fragments were removed, and another anchor was used to complete the case.This was discovered during a slap repair procedure on 3/21/2024.Additional information received on 3/27/2024: the case was not delayed and additional anesthesia was not needed.The patient suffered no negative effects.
 
Additional Manufacturer Narrative
The contribution of the device to the reported event could not be determined as the device was not returned for evaluation.The root cause of the event could not be determined from the information available and without device evaluation.If the device becomes available for evaluation, a follow-up report will be submitted.
 
Additional Manufacturer Narrative
The complaint allegation is confirmed.One unpackaged ar-2923bc serial/batch number (b)(6) was received for investigation.The visual evaluation showed that the anchor had broken off, with only a small fragment returned for evaluation.Functional testing was not performed due to the damage to the received device.The method of bone quality encountered, was described as a hard.The most likely cause(s) for the reported failure can be user error, improper bone preparation, misaligned insertion, or excessive force by leveraging/prying the device.According to dfu-0087 at revision 13.E.Warnings.6.Bio-absorbable only: attempting implantation into hard, dense bone and/or drilling/punching smaller diameter holes than recommended may cause failure (breakage) of the implant during insertion.G.Precautions.4.Pushlock and swivelock suture anchors only: during anchor insertion, ensure that the angle of anchor insertion is coaxial to that of the previously prepared bone socket.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUTR ANCH,BIO-COMP P-LCK,2.9X 12.5MM
Common Device Name
BIO SOFT TISSUE FIXATN FASTNR
Manufacturer (Section D)
ARTHREX, INC.
1370 creekside boulevard
naples FL 34108 1945
Manufacturer (Section G)
ARTHREX, INC.
1370 creekside boulevard
naples FL 34108 1945
Manufacturer Contact
jared engle
8009337001
MDR Report Key19126399
Report Number1220246-2024-02086
Device Sequence Number7722599
Product Code MAI
UDI-Device Identifier00888867099203
UDI-Public00888867099203
Combination Product (Y/N)N
Initial Reporter StateNV
Initial Reporter CountryUS
PMA/510(K) Number
K101679
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Distributor
Initial Reporter Occupation Administrator/Supervisor
Type of Report Initial,Followup
Report Date (Section B) 08/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/31/2025
Device Model NumberSUTR ANCH,BIO-COMP P-LCK,2.9X 12.5MM
Device Catalogue NumberAR-2923BC
Device Lot Number15099318
Was Device Available for Evaluation? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/22/2024
Supplement Date Received by Manufacturer07/23/2024
Initial Report FDA Received Date04/17/2024
Supplement Report FDA Received Date08/20/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured06/01/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-